ABSTRACT
Early-onset psychosis disorders are serious mental disorders arising before the age of 18 years. Here, we investigate the largest neuroimaging dataset, to date, of patients with early-onset psychosis and healthy controls for differences in intracranial and subcortical brain volumes. The sample included 263 patients with early-onset psychosis (mean age: 16.4 ± 1.4 years, mean illness duration: 1.5 ± 1.4 years, 39.2% female) and 359 healthy controls (mean age: 15.9 ± 1.7 years, 45.4% female) with magnetic resonance imaging data, pooled from 11 clinical cohorts. Patients were diagnosed with early-onset schizophrenia (n = 183), affective psychosis (n = 39), or other psychotic disorders (n = 41). We used linear mixed-effects models to investigate differences in intracranial and subcortical volumes across the patient sample, diagnostic subgroup and antipsychotic medication, relative to controls. We observed significantly lower intracranial (Cohen's d = -0.39) and hippocampal (d = -0.25) volumes, and higher caudate (d = 0.25) and pallidum (d = 0.24) volumes in patients relative to controls. Intracranial volume was lower in both early-onset schizophrenia (d = -0.34) and affective psychosis (d = -0.42), and early-onset schizophrenia showed lower hippocampal (d = -0.24) and higher pallidum (d = 0.29) volumes. Patients who were currently treated with antipsychotic medication (n = 193) had significantly lower intracranial volume (d = -0.42). The findings demonstrate a similar pattern of brain alterations in early-onset psychosis as previously reported in adult psychosis, but with notably low intracranial volume. The low intracranial volume suggests disrupted neurodevelopment in adolescent early-onset psychosis.
Subject(s)
Adolescent Development/physiology , Affective Disorders, Psychotic/pathology , Brain/pathology , Psychotic Disorders/pathology , Schizophrenia/pathology , Adolescent , Affective Disorders, Psychotic/diagnostic imaging , Age of Onset , Brain/diagnostic imaging , Globus Pallidus/diagnostic imaging , Globus Pallidus/pathology , Hippocampus/diagnostic imaging , Hippocampus/pathology , Humans , Magnetic Resonance Imaging , Psychotic Disorders/diagnostic imaging , Schizophrenia/diagnostic imagingABSTRACT
Treatment resistance (TR) in patients with first-episode psychosis (FEP) is a major cause of disability and functional impairment, yet mechanisms underlying this severe disorder are poorly understood. As one view is that TR has neurodevelopmental roots, we investigated whether its emergence relates to disruptions in synchronized cortical maturation quantified using gyrification-based connectomes. Seventy patients with FEP evaluated at their first presentation to psychiatric services were followed up using clinical records for 4 years; of these, 17 (24.3%) met the definition of TR and 53 (75.7%) remained non-TR at 4 years. Structural MRI images were obtained within 5 weeks from first exposure to antipsychotics. Local gyrification indices were computed for 148 contiguous cortical regions using FreeSurfer; each subject's contribution to group-based structural covariance was quantified using a jack-knife procedure, providing a single deviation matrix for each subject. The latter was used to derive topological properties that were compared between TR and non-TR patients using a Functional Data Analysis approach. Compared to the non-TR patients, TR patients showed a significant reduction in small-worldness (Hedges's g = 2.09, P < .001) and a reduced clustering coefficient (Hedges's g = 1.07, P < .001) with increased length (Hedges's g = -2.17, P < .001), indicating a disruption in the organizing principles of cortical folding. The positive symptom burden was higher in patients with more pronounced small-worldness (r = .41, P = .001) across the entire sample. The trajectory of synchronized cortical development inferred from baseline MRI-based structural covariance highlights the possibility of identifying patients at high-risk of TR prospectively, based on individualized gyrification-based connectomes.
Subject(s)
Affective Disorders, Psychotic/pathology , Antipsychotic Agents/pharmacology , Cerebral Cortex/pathology , Nerve Net/pathology , Psychotic Disorders/pathology , Schizophrenia/pathology , Adolescent , Adult , Affective Disorders, Psychotic/diagnostic imaging , Affective Disorders, Psychotic/drug therapy , Cerebral Cortex/diagnostic imaging , Clozapine/pharmacology , Female , Follow-Up Studies , Humans , Longitudinal Studies , Magnetic Resonance Imaging , Male , Nerve Net/diagnostic imaging , Psychotic Disorders/diagnostic imaging , Psychotic Disorders/drug therapy , Schizophrenia/diagnostic imaging , Schizophrenia/drug therapy , Young AdultABSTRACT
BACKGROUND: Functional connectivity abnormalities between Broca's and Wernicke's areas and the putamen revealed by functional magnetic resonance imaging (fMRI) are related to auditory hallucinations (AH). In long-term schizophrenia, reduced white matter structural integrity revealed by diffusion imaging in left arcuate fasciculus (connecting Broca's and Wernicke's areas) is likely related to AH. The structural integrity of connections with putamen and their relation to AH are unknown. Little is known about this relationship in first-episode psychosis (FEP), although auditory transcallosal connections were reported to play a role. White matter in the Broca's-Wernicke's-putamen language-related circuit and auditory transcallosal fibers was examined to investigate associations with AH in FEP. METHODS: White matter connectivity was measured in 40 FEP and 32 matched HC using generalized fractional anisotropy (gFA) derived from diffusion spectrum imaging (DSI). RESULTS: FEP and HC did not differ in gFA in any fiber bundle. In FEP, AH severity was significantly inversely related to gFA in auditory transcallosal fibers and left arcuate fasciculus. Although the right hemisphere arcuate fasciculus-AH association did not attain significance, the left and right arcuate fasciculus associations were not significantly different. CONCLUSIONS: Despite overall normal gFA in FEP, AH severity was significantly related to gFA in transcallosal auditory fibers and the left hemisphere connection between Broca's and Wernicke's areas. Other bilateral tracts' gFA were weakly associated with AH. At the first psychotic episode, AH are more robustly associated with left hemisphere arcuate fasciculus and interhemispheric auditory fibers microstructural deficits, likely reflecting mistiming of information flow between language-related cortical centers.
Subject(s)
Affective Disorders, Psychotic/pathology , Auditory Perception , Broca Area/pathology , Corpus Callosum/pathology , Hallucinations/pathology , Psychotic Disorders/pathology , Putamen/pathology , Schizophrenia/pathology , Wernicke Area/pathology , White Matter/pathology , Adolescent , Adult , Affective Disorders, Psychotic/diagnostic imaging , Broca Area/diagnostic imaging , Corpus Callosum/diagnostic imaging , Diffusion Magnetic Resonance Imaging , Female , Hallucinations/diagnostic imaging , Humans , Male , Neural Pathways/diagnostic imaging , Neural Pathways/pathology , Psychotic Disorders/diagnostic imaging , Putamen/diagnostic imaging , Schizophrenia/diagnostic imaging , Wernicke Area/diagnostic imaging , White Matter/diagnostic imaging , Young AdultABSTRACT
OBJECTIVE: To assess cortical thickness (CT) and surface area (SA) of frontal, temporal, and parietal brain regions in a large clinical high risk for psychosis (CHR) sample, and to identify cortical brain abnormalities in CHR who convert to psychosis and in the whole CHR sample, compared with the healthy controls (HC). METHODS: Magnetic resonance imaging, clinical, and cognitive data were acquired at baseline in 92 HC, 130 non-converters, and 22 converters (conversion assessed at 1-year follow-up). CT and SA at baseline were calculated for frontal, temporal, and parietal subregions. Correlations between regions showing group differences and clinical scores and age were also obtained. RESULTS: CT but not SA was significantly reduced in CHR compared with HC. Two patterns of findings emerged: (1) In converters, CT was significantly reduced relative to non-converters and controls in the banks of superior temporal sulcus, Heschl's gyrus, and pars triangularis and (2) CT in the inferior parietal and supramarginal gyrus, and at trend level in the pars opercularis, fusiform, and middle temporal gyri was significantly reduced in all high-risk individuals compared with HC. Additionally, reduced CT correlated significantly with older age in HC and in non-converters but not in converters. CONCLUSIONS: These results show for the first time that fronto-temporo-parietal abnormalities characterized all CHR, that is, both converters and non-converters, relative to HC, while CT abnormalities in converters relative to CHR-NC and HC were found in core auditory and language processing regions.
Subject(s)
Affective Disorders, Psychotic/pathology , Cerebral Cortex/pathology , Disease Progression , Language , Nerve Net/pathology , Psychotic Disorders/pathology , Schizophrenia/pathology , Adolescent , Adult , Affective Disorders, Psychotic/diagnostic imaging , Affective Disorders, Psychotic/physiopathology , Cerebral Cortex/diagnostic imaging , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Nerve Net/diagnostic imaging , Psychotic Disorders/diagnostic imaging , Psychotic Disorders/physiopathology , Risk , Schizophrenia/diagnostic imaging , Schizophrenia/physiopathology , Young AdultABSTRACT
Antidepressants are commonly prescribed psychotropic substances for the symptomatic treatment of mood disorders. Their primary mechanism of action is the modulation of neurotransmission and the consequent accumulation of monoamines, such as serotonin and noradrenaline. However, antidepressants have additional molecular targets that, through multiple signaling cascades, may ultimately alter essential cellular processes. In this regard, it was previously demonstrated that clomipramine, a widely used FDA-approved tricyclic antidepressant, interferes with the autophagic flux and severely compromises the viability of tumorigenic cells upon cytotoxic stress. Consistent with this line of evidence, we report here that clomipramine undermines autophagosome formation and cargo degradation in primary dissociated neurons. A similar pattern was observed in the frontal cortex and liver of treated mice, as well as in the nematode Caenorhabditis elegans exposed to clomipramine. Together, our findings indicate that clomipramine may negatively regulate the autophagic flux in various tissues, with potential metabolic and functional implications for the homeostatic maintenance of differentiated cells.
Subject(s)
Affective Disorders, Psychotic/drug therapy , Antidepressive Agents, Tricyclic/pharmacology , Clomipramine/pharmacology , Neurons/drug effects , Affective Disorders, Psychotic/pathology , Animals , Antidepressive Agents, Tricyclic/adverse effects , Autophagy/drug effects , Caenorhabditis elegans/drug effects , Clomipramine/adverse effects , Disease Models, Animal , Liver/drug effects , Liver/metabolism , Mice , Neurons/metabolism , Norepinephrine/metabolism , Serotonin/metabolism , Signal Transduction/drug effectsABSTRACT
BACKGROUND: Non-affective and affective psychoses are very common mental disorders. However, their neurobiological underpinnings are still poorly understood. Therefore, the goal of the present review was to evaluate structural Magnetic Resonance Imaging (MRI) studies exploring brain deficits in both non-affective (NA-FEP) and affective first episode psychosis (A-FEP). METHODS: A bibliographic search on PUBMED of all MRI studies exploring gray matter (GM) differences between NA-FEP and A-FEP was conducted. RESULTS: Overall, the results from the available evidence showed that the two diagnostic groups share common GM alterations in fronto-temporal regions and anterior cingulate cortex. In contrast, unique GM deficits have also been observed, with reductions in amygdala for A-FEP and in hippocampus and insula for NA-FEP. LIMITATIONS: Few small MRI studies with heterogeneous methodology. CONCLUSIONS: Although the evidences are far to be conclusive, they suggest the presence of common and distinct pattern of GM alterations in NA-FEP and A-FEP. Future larger longitudinal studies are needed to further characterize specific neural biomarkers in homogenous NA-FEP and A-FEP samples.
Subject(s)
Affective Disorders, Psychotic/pathology , Gray Matter/pathology , Psychotic Disorders/pathology , Amygdala/pathology , Anxiety Disorders/pathology , Cerebral Cortex/pathology , Gyrus Cinguli/pathology , Hippocampus/pathology , Humans , Magnetic Resonance Imaging/methods , Mood Disorders/pathology , Research , Temporal Lobe/pathologyABSTRACT
The aim of this paper was to investigate differences in brain structure volumes between schizophrenia and affective psychoses, and whether cumulative lifetime antipsychotic or benzodiazepine doses relate to brain morphology in these groups. We conducted two systematic reviews on the topic and investigated 44 schizophrenia cases and 19 with affective psychoses from the Northern Finland Birth Cohort 1966. The association between lifetime antipsychotic and benzodiazepine dose and brain MRI scans at the age of 43 was investigated using linear regression. Intracranial volume, sex, illness severity, and antipsychotic/benzodiazepine doses were used as covariates. There were no differences between the groups in brain structure volumes. In schizophrenia, after adjusting for benzodiazepine dose and symptoms, a negative association between lifetime antipsychotic dose and the nucleus accumbens volume remained. In affective psychoses, higher lifetime benzodiazepine dose associated with larger volumes of total gray matter and hippocampal volume after controlling for antipsychotic use and symptoms. It seems that in addition to antipsychotics, the severity of symptoms and benzodiazepine dose are also associated with brain structure volumes. These results suggest, that benzodiazepine effects should also be investigated also independently and not only as a confounder.
Subject(s)
Affective Disorders, Psychotic/pathology , Antipsychotic Agents/therapeutic use , Benzodiazepines/therapeutic use , Brain/pathology , Schizophrenia/pathology , Adult , Affective Disorders, Psychotic/diagnostic imaging , Affective Disorders, Psychotic/drug therapy , Cohort Studies , Female , Finland , Humans , Linear Models , Magnetic Resonance Imaging , Male , Organ Size/drug effects , Schizophrenia/diagnostic imaging , Schizophrenia/drug therapyABSTRACT
Psychotic bipolar disorder (P-BD) is a specific subset that presents greater risk of relapse and worse outcomes than nonpsychotic bipolar disorder (NP-BD). To explore the neuroanatomical bases of psychotic dimension in bipolar disorder (BD), a systematic review was carried out based on the gray matter volume (GMV) among P-BD and NP-BD patients and healthy controls (HC). Further, we conducted a meta-analysis of GMV differences between P-BD patients and HC using a whole-brain imaging approach. Our review revealed that P-BD patients exhibited smaller GMVs mainly in the prefronto-temporal and cingulate cortices, the precentral gyrus, and insula relative to HC both qualitatively and quantitatively. Qualitatively the comparison between P-BD and NP-BD patients suggested inconsistent GMV alterations mainly involving the prefrontal cortex, while NP-BD patients showed GMV deficits in local regions compared with HC. The higher proportions of female patients and patients taking psychotropic medication in P-BD and P-BD type I were associated with smaller GMV in the right precentral gyrus, and the right insula, respectively. In conclusions, psychosis in BD might be associated with specific cortical GMV deficits. Gender and psychotropic medication might have effects on the regional GMVs in P-BD patients. It is necessary to distinguish psychotic dimension in neuroimaging studies of BD.
Subject(s)
Affective Disorders, Psychotic/pathology , Bipolar Disorder/pathology , Gray Matter/pathology , Neuroimaging , Adult , Affective Disorders, Psychotic/diagnostic imaging , Affective Disorders, Psychotic/physiopathology , Bipolar Disorder/diagnostic imaging , Bipolar Disorder/physiopathology , Gray Matter/diagnostic imaging , Humans , Neuroimaging/methods , Neuroimaging/statistics & numerical dataABSTRACT
Although the insula and temporal pole (TP) of paralimbic regions are important in both affective and cognitive processing, it is not well known whether gray matter volume (GMV) abnormalities in these regions show post-onset progression and differentially affect first-episode schizophrenia (FESZ) and first-episode affective psychosis (FEAFF) patients. To determine whether there are initial and progressive GMV deficits in insula and TP in FESZ and FEAFF (mainly manic) patients, their relative specificity to FESZ or FEAFF, and relationship to symptoms, we conducted a naturalistic study at first hospitalization for psychosis and follow-up ~1.5 years later. Initial 1.5T magnetic resonance imaging (MRI) scans and follow-up scans were on the same scanner. Twenty-two FESZ, 23 FEAFF, and 23 healthy control (HC) subjects were group matched for age, gender, parental socioeconomic status, and handedness. At first hospitalization, FESZ showed significantly smaller bilateral insular GMV compared with FEAFF, and smaller left TP GMV compared with FEAFF and HC. Moreover, on 1.5 years follow-up, FESZ showed progressive GMV decreases in bilateral insula compared with FEAFF and HC, and in TP GMV compared with HC. In contrast, FEAFF showed no progression. Progression of FESZ GMV in both insula and TP was inversely associated with changes in the overall Brief Psychiatric Rating Scale symptom score, indicating less improvement or worsening of symptoms.
Subject(s)
Affective Disorders, Psychotic/pathology , Cerebral Cortex/pathology , Disease Progression , Gray Matter/pathology , Schizophrenia/pathology , Adolescent , Adult , Affective Disorders, Psychotic/physiopathology , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Schizophrenia/physiopathology , Temporal Lobe/pathology , Young AdultABSTRACT
BACKGROUND: Magnetic resonance imaging (MRI) studies have shown that brain abnormalities in psychosis might be progressive during the first years of illness. We sought to determine whether first-episode psychosis (FEP) subjects show progressive regional grey matter (GM) changes compared with controls, and whether those changes are associated with diagnosis, illness course or antipsychotic (AP) use. METHOD: Thirty-two subjects with first-episode schizophrenia-spectrum disorders (FESZ), 24 patients with first-episode affective psychoses (FEAP) and 34 controls recruited using a population-based design underwent structural MRI scanning at baseline and at a 5-year follow-up. Regional GM volumes were assessed with voxel-based morphometry (VBM). Patients were treated at community settings, and about half of them remained mainly untreated. RESULTS: No significant progressive changes in GM regional volumes were observed in either the FESZ or FEAP group overall. However, FESZ subjects with a non-remitting course showed GM decrements in the left superior temporal gyrus (STG) and insula relative to remitted FESZ subjects. Non-remitted FEAP subjects exhibited a GM decrease in the dorsolateral prefrontal cortex (DLPFC) bilaterally in comparison to remitted FEAP subjects. Among FESZ subjects, AP use was associated with regional GM decrements in the right insula and increments in the cerebellum. CONCLUSIONS: Our results suggest that the progression of brain abnormalities in FEP subjects is restricted to those with a poor outcome and differs between diagnosis subgroups. AP intake is associated with a different pattern of GM reductions over time.
Subject(s)
Affective Disorders, Psychotic/pathology , Cerebral Cortex/pathology , Gray Matter/pathology , Magnetic Resonance Imaging/methods , Schizophrenia/pathology , Adult , Female , Follow-Up Studies , Humans , MaleABSTRACT
BACKGROUND: Psychotic depression is arguably the most diagnostically stable subtype of major depressive disorder, and an attractive target of study in a famously heterogeneous mental illness. Previous imaging studies have identified abnormal volumes of the hippocampus, amygdala, and subcallosal region of the anterior cingulate cortex (scACC) in psychotic depression, though studies have not yet examined the role of family history of depression in these relationships. METHODS: 20 participants with psychotic depression preparing to undergo electroconvulsive therapy and 20 healthy comparison participants (13 women and 7 men in each group) underwent structural brain imaging in a 1.5 T MRI scanner. 15 of the psychotic depression group had a first-degree relative with diagnosed affective disorders, while the healthy control group had no first-degree relatives with affective disorders. Depression severity was assessed with the Hamilton Depression Rating Scale and duration of illness was assessed in all patients. Automated neural nets were used to isolate the hippocampi and amygdalae in each scan, and an established manual method was used to parcellate the anterior cingulate cortex into dorsal, rostral, subcallosal, and subgenual regions. The volumes of these regions were compared between groups. Effects of laterality and family history of affective disorders were examined as well. RESULTS: Patients with psychotic depression had significantly smaller left scACC and bilateral hippocampal volumes, while no group differences in other anterior cingulate cortex subregions or amygdala volumes were present. Hippocampal atrophy was found in all patients with psychotic depression, but reduced left scACC volume was found only in the patients with a family history of depression. CONCLUSIONS: Patients with psychotic depression showed significant reduction in hippocampal volume bilaterally, perhaps due to high cortisol states associated with this illness. Reduced left scACC volume may be a vulnerability factor related to family history of depression.
Subject(s)
Affective Disorders, Psychotic/pathology , Depression/pathology , Gyrus Cinguli/pathology , Hippocampus/pathology , Prefrontal Cortex/pathology , Adult , Atrophy , Case-Control Studies , Female , Humans , Male , Middle Aged , Organ SizeABSTRACT
The relationship between major depressive disorder with psychotic (MDDP) features and schizophrenia has long been recognized, and the neurobiological boundaries between these disorders can nowadays be investigated using neuroimaging techniques. This article provides a critical review of such studies, addressing how they support a dimensional approach to the nosology and pathophysiology of psychotic disorders. A proportion of neuroimaging studies carried out to date indicate that MDDP subjects display structural and functional abnormalities in some brain regions specifically implicated in the pathophysiology of mood disorders, such as the subgenual cingulate cortex. This reinforces the validity of the classification of MDDP in proximity to major depression without psychosis. There is some neuroimaging evidence that MDDP may be associated with additional brain abnormalities relative to nonpsychotic major depression although less prominently in comparison with findings from the neuroimaging literature on schizophrenia. Brain regions seen as critical both to emotional processing and to models of psychotic symptoms, such as the hippocampus, insula, and lateral prefrontal cortex, have been implicated in separate neuroimaging investigations of either schizophrenia or major depression, as well as in some studies that directly compared depressed patients with and without psychotic features. These brain regions are key targets for future studies designed to validate imaging phenotypes more firmly associated with MDDP, as well as to investigate the relationship between these phenotypes and possible etiological influences for MDDP.
Subject(s)
Affective Disorders, Psychotic/pathology , Brain/pathology , Depressive Disorder, Major/pathology , Functional Neuroimaging , Affective Disorders, Psychotic/physiopathology , Affective Disorders, Psychotic/psychology , Bipolar Disorder/pathology , Bipolar Disorder/physiopathology , Brain/diagnostic imaging , Brain/physiopathology , Brain Mapping , Depressive Disorder, Major/physiopathology , Depressive Disorder, Major/psychology , Humans , Magnetic Resonance Imaging , Organ Size , Positron-Emission Tomography , Schizophrenia/pathology , Schizophrenia/physiopathology , Tomography, Emission-Computed, Single-PhotonABSTRACT
The neurobiological correlates of impaired insight in psychotic illness remain uncertain and may be confounded by factors such as illness progression and medication use. Our study consisted of two separate experiments. In the first experiment, we examined the association between measures of insight and regional brain volume in thirty-two patients with first-episode psychosis. In the second experiment, we looked at similar associations in thirty individuals with chronic schizophrenia. Detailed measures of symptom awareness and symptom attribution were obtained using the Scale to assess Unawareness of Mental Disorder. MRI scans were acquired and analysed using Statistical Non-Parametric Mapping for voxel-based analyses of grey matter maps. Regression models were used to assess the relationship between insight and grey matter volume in both the first-episode psychosis and the chronic schizophrenia experiments whilst controlling for potential confounds. In first-episode psychosis patients, symptom misattribution was associated with increased grey matter in the right and left caudate, right thalamus, left insula, putamen and cerebellum. In the chronic schizophrenia study, there were no significant associations between regional grey matter volume and measures of insight. These findings suggest that neuroplastic changes within subcortical and frontotemporal regions are associated with impaired insight in individuals during their first episode of psychosis.
Subject(s)
Affective Disorders, Psychotic/pathology , Brain/pathology , Nerve Fibers, Unmyelinated/pathology , Psychotic Disorders/pathology , Schizophrenia/pathology , Schizophrenic Psychology , Adolescent , Adult , Affective Disorders, Psychotic/psychology , Cerebellum/pathology , Cerebral Cortex/pathology , Female , Humans , Image Processing, Computer-Assisted , Magnetic Resonance Imaging , Male , Middle Aged , Neostriatum/pathology , Organ Size , Psychotic Disorders/psychology , Regression Analysis , Thalamus/pathology , Young AdultABSTRACT
La Organización Mundial de la Salud (OMS) y la Liga Internacional contra la Epilepsia (ILAE), la definen como una afección neurológica crónica, recurrente y repetitiva de fenómenos paroxíticos, ocasionados por descargas neuronales desorganizadas y excesivas. La epilepsia es la condición neurológica más seria y más común. Se estima que la prevalencia actual del trastorno es de 5-10/1000 personas; excluyendo a las convulsiones febriles, los casos de una crisis única y los casos inactivos. Sus causas pueden ser muy diversas y sus manfiestaciones muy variadas, de esta manera su sintomatología se ubica dentro de un polimorfismo acentuado. Dentro de las posibles manfiestaciones clínicas que pueden presentarse, se encuentran aquellas en las que predominan las alteraciones conductuales. El objetivo de la presente revisión es el poder dar cuenta de la presentación de los síntomas psiquiátricos en epilepsia, el impacto de estos y la importancia del manejo interdisciplinario con neurólogos. El reconocimiento de estos cuadros resulta de suma importancia en la práctica de la interconsulta, dada la implicancia de los profesionales de salud mental en el manejo sintomático de dichas manifestaciones.
The World Health Organization (WHO) and the International League Against Epilepsy (ILAE) define epilepsy as a chronic neurological affection, characterized by recurrent and repetitive paroxysmal phenomena generated by disorganized and excessive neuronal discharges. Epilepsy is the most serious and frequent neurological condition. It is estimated that its current prevalence is 5-10/1,000 people; excluding febrile seizures, single seizures and inactive cases. Because its causes and manifestations can be very varied, its symptomatology is placed with in a marked polymorphism. Among the possible clinical manifestations that may appear are those in which behavioral alterations prevail. The aim of this review is to describe the onset of psychiatric symptoms in epilepsy, their impact and the importance of interdisciplinary management of this disease with Neurologists. Identifying these clincal symptoms is of the utmost importance, given the involvement of healthcare profesionals in the symptomatic treatment of those manifestations.
Subject(s)
Humans , Female , Middle Aged , Biological Psychiatry , Epilepsy/pathology , Neurology , Psychic Symptoms , Affective Disorders, Psychotic/pathology , Neurocognitive Disorders/pathology , Neurocognitive Disorders/psychologyABSTRACT
La Organización Mundial de la Salud (OMS) y la Liga Internacional contra la Epilepsia (ILAE), la definen como una afección neurológica crónica, recurrente y repetitiva de fenómenos paroxíticos, ocasionados por descargas neuronales desorganizadas y excesivas. La epilepsia es la condición neurológica más seria y más común. Se estima que la prevalencia actual del trastorno es de 5-10/1000 personas; excluyendo a las convulsiones febriles, los casos de una crisis única y los casos inactivos. Sus causas pueden ser muy diversas y sus manfiestaciones muy variadas, de esta manera su sintomatología se ubica dentro de un polimorfismo acentuado. Dentro de las posibles manfiestaciones clínicas que pueden presentarse, se encuentran aquellas en las que predominan las alteraciones conductuales. El objetivo de la presente revisión es el poder dar cuenta de la presentación de los síntomas psiquiátricos en epilepsia, el impacto de estos y la importancia del manejo interdisciplinario con neurólogos. El reconocimiento de estos cuadros resulta de suma importancia en la práctica de la interconsulta, dada la implicancia de los profesionales de salud mental en el manejo sintomático de dichas manifestaciones.(AU)
The World Health Organization (WHO) and the International League Against Epilepsy (ILAE) define epilepsy as a chronic neurological affection, characterized by recurrent and repetitive paroxysmal phenomena generated by disorganized and excessive neuronal discharges. Epilepsy is the most serious and frequent neurological condition. It is estimated that its current prevalence is 5-10/1,000 people; excluding febrile seizures, single seizures and inactive cases. Because its causes and manifestations can be very varied, its symptomatology is placed with in a marked polymorphism. Among the possible clinical manifestations that may appear are those in which behavioral alterations prevail. The aim of this review is to describe the onset of psychiatric symptoms in epilepsy, their impact and the importance of interdisciplinary management of this disease with Neurologists. Identifying these clincal symptoms is of the utmost importance, given the involvement of healthcare profesionals in the symptomatic treatment of those manifestations.(AU)
Subject(s)
Humans , Female , Middle Aged , Epilepsy/pathology , Neurocognitive Disorders/pathology , Neurocognitive Disorders/psychology , Affective Disorders, Psychotic/pathology , Psychic Symptoms , Biological Psychiatry , NeurologyABSTRACT
Major depressive disorder (MDD) is a leading cause of disability worldwide and results tragically in the loss of almost one million lives in Western societies every year. This is due to poor understanding of the disease pathophysiology and lack of empirical medical tests for accurate diagnosis or for guiding antidepressant treatment strategies. Here, we have used shotgun proteomics in the analysis of post-mortem dorsolateral prefrontal cortex brain tissue from 24 MDD patients and 12 matched controls. Brain proteomes were pre-fractionated by gel electrophoresis and further analyzed by shotgun data-independent label-free liquid chromatography-mass spectrometry. This led to identification of distinct proteome fingerprints between MDD and control subjects. Some of these differences were validated by Western blot or selected reaction monitoring mass spectrometry. This included proteins associated with energy metabolism and synaptic function and we also found changes in the histidine triad nucleotide-binding protein 1 (HINT1), which has been implicated recently in regulation of mood and behavior. We also found differential proteome profiles in MDD with (n=11) and without (n=12) psychosis. Interestingly, the psychosis fingerprint showed a marked overlap to changes seen in the brain proteome of schizophrenia patients. These findings suggest that it may be possible to contribute to the disease understanding by distinguishing different subtypes of MDD based on distinct brain proteomic profiles.
Subject(s)
Affective Disorders, Psychotic/genetics , Depressive Disorder, Major/genetics , Prefrontal Cortex/metabolism , Prefrontal Cortex/pathology , Proteomics , Transcriptome/genetics , Adult , Affective Disorders, Psychotic/pathology , Depressive Disorder, Major/pathology , Female , Humans , Male , Mass Spectrometry , Middle Aged , Nerve Tissue Proteins/genetics , Peptide Mapping , Schizophrenia/genetics , Schizophrenia/pathologyABSTRACT
El Síndrome de Apnea Obstructiva del Sueño (SAOS) es una alteración del sueño que frecuentemente se asocia a una gran diversidad de patologías, como la hipertensión arterial, enfermedades cardiovasculares, neuropsicológicas o metabólicas. La sintomatología más común y destacada de la apnea es la excesiva somnolencia diurna, así como alteraciones de la memoria y concentración, irritabilidad, cefaleas, y depresión, entre otras. Hasta la fecha no se conocen estudios que hayan relacionado el SAOS con otro tipo de alteraciones psiquiátricas más graves, como por ejemplo, la sintomatología psicótica. A continuación presentamos el caso de un varón de 51 años de edad que, tras presentar sintomatología psicótica y afectiva que no remitía con ningún fármaco, fue diagnosticado de SAOS, cuyo tratamiento logró la remisión completa de la sintomatología psiquiátrica (AU)
Obstructive Sleep Apnoea Syndrome (OSAS) is an alteration of the dream that frequently is associated to a great diversity of patologies, as hypertension, cardiovascular, neuropsychologycal or metabolic diseases. The most common and emphasized symptomatology of the apnoea is the excessive diurnal drowsiness, as well as alterations of the memory and concentration, irritability, migraines, and depression, among others. Up to the date there are not known studies that related the OSAS to another type of more serious psychiatric alterations, like for example, the psychotic symptomatology. Later we report the case of a 51-year-old male of age who, after presenting psychotic and affective symptomatology that was not sending with any medicament, was diagnosed of SAOS, whose treatment achieved the complete reference of the mentioned psychiatric symptomatology (AU)
Subject(s)
Humans , Male , Middle Aged , Sleep Apnea, Obstructive/diagnosis , Sleep Apnea, Obstructive/pathology , Affective Disorders, Psychotic/diagnosis , Affective Disorders, Psychotic/pathology , Sleep Apnea, Obstructive/complications , Sleep Apnea, Obstructive/history , Sleep Apnea, Obstructive/psychology , Affective Disorders, Psychotic/classificationABSTRACT
OBJECTIVE: A history of childhood trauma is common in individuals who later develop psychosis. Similar neuroanatomical abnormalities are observed in people who have been exposed to childhood trauma and people with psychosis. However, the relationship between childhood trauma and such abnormalities in psychosis has not been investigated. This study aimed to explore the association between the experience of childhood trauma and hippocampal and amygdalar volumes in a first-episode psychosis (FEP) population. METHODS: The study employed an observational retrospective design. Twenty-one individuals, who had previously undergone magnetic resonance imaging procedures as part of the longitudinal Northern Ireland First-Episode Psychosis Study, completed measures assessing traumatic experiences and were included in the analysis. Data were subject to correlation analyses (r and r (pb)). Potential confounding variables (age at FEP and delay to scan from recruitment) were selected a priori for inclusion in multiple regression analyses. RESULTS: There was a high prevalence of lifetime (95%) and childhood (76%) trauma in the sample. The experience of childhood trauma was a significant predictor of left hippocampal volume, although age at FEP also significantly contributed to this model. There was no significant association between predictor variables and right hippocampal volume. The experience of childhood trauma was a significant predictor of right and total amygdalar volumes and the hippocampal/amygdalar complex volume as a whole. CONCLUSIONS: The findings indicate that childhood trauma is associated with neuroanatomical measures in FEP. Future research controlling for childhood traumatic experiences may contribute to explaining brain morphology in people with psychosis.
Subject(s)
Adult Survivors of Child Abuse/psychology , Amygdala/pathology , Hippocampus/pathology , Psychotic Disorders/pathology , Adult , Affective Disorders, Psychotic/pathology , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Organ Size , Regression Analysis , Retrospective StudiesABSTRACT
En este artículo estudiamos a dos mujeres distímicas a quiénes tratamos mediante psicoterapia y, a partir de ahí, se pusieron de manifiesto aquellos componentes internos que sustentan los síntomas depresivos. Estos mismos hallazgos se confirmaron en otras pacientes con idéntico diagnóstico. El resultado consistió en descubrir una desinserción sentimental respecto a sus parejas, permaneciendo con ellos sin separarse, al tiempo que van apareciendo insidiosamente las manifestaciones depresivas. Este desarrollo las lleva a la caída del ideal de amor al que aspiraban, que sostenía sus vidas y funcionaba como una agarradera de la personalidad. Tales apreciaciones ponen en cuestión las nociones clásicas acerca del duelo (AU)
In this article, we study two dysthymic women who we are treating with psychotherapy in order to reveal the inner components that maintain depressive symptoms. The same findings have been confirmed in other dysthymic patients. The result of the study consisted in discovering a sentimental separation from their love object, while the woman still lives with her partner and while the depressive symptoms are appearing insidiously. This development leads them to the deterioration in the ideal of love they sought, that supported their lives and served as an anchor of their personality. This point of view places classic notion about mourning into doubt (AU)